PLASMA BASED CELL-FREE CIRCULATING TUMOR DNA (CTDNA) ASSESSMENT FOR NON-INVASIVE DETECTION OF COLORECTAL CANCER (CRC)

被引:0
|
作者
Dean, Jason
He, Yupeng
Raymond, Victoria
Kim, Seung Tae
Lee, Jeeyun
Kim, Hee Cheol
Jaimovich, Ariel
Talasaz, AmirAli
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1651
引用
收藏
页码:S369 / S369
页数:1
相关论文
共 50 条
  • [41] Plasma central carbon metabolite changes associated with KRAS mutation and circulating tumor DNA (ctDNA) status in colorectal cancer (CRC).
    Kim, Daniel Myung
    Aguirre, Francesca Paola
    Gangi, Alexandra
    Alvarez, Rocio
    Zhou, Lisa
    ten Hoeve, Johanna
    Liao, Yi Jou
    Graeber, Thomas
    Hendifar, Andrew Eugene
    Osipov, Arsen
    Sankar, Kamya
    Cho, May Thet
    Abbas, Anser
    Davelaar, John
    Hitchins, Megan Philippa
    Gong, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 181 - 181
  • [42] Diagnostic und Therapeutic Value of Cell-free Circulating DNA as a Non-invasive Biomarker in Patients with Prostate Cancer
    Latz, Stefan
    Mueller, Stefan C.
    Ellinger, Joerg
    CURRENT CANCER THERAPY REVIEWS, 2013, 9 (04) : 258 - 264
  • [43] Use of Plasma Cell-Free DNA as Prognostic and Predictive Biomarker in Non-Invasive Analysis of Breast Cancer
    Xu, Fei
    JOURNAL OF WOMENS HEALTH, 2015, 24 (04) : 49 - 49
  • [44] Serial assessment of cell-free circulating tumor DNA (ctDNA) to assess treatment effect and minimal residual disease during neoadjuvant and adjuvant therapy in colorectal cancer
    Parikh, A.
    Van Seventer, E.
    Boland, G.
    Hartwig, A.
    Jaimovich, A.
    Raymond, V.
    Talasaz, A.
    Corcoran, R.
    ANNALS OF ONCOLOGY, 2019, 30
  • [45] Comprehensive non-invasive tumor sequencing: High fidelity sequencing of tumor-derived circulating cell-free DNA across 300 cancer patients
    Mortimer, Stefanie A.
    Sebisanovic, Dragan
    Mei, Gangwu
    Schiller, Benjamin
    Siew, Lai Mun
    Zapanta, Aubrey
    Eltoukhy, Helmy
    Talasaz, AmirAli
    CANCER RESEARCH, 2014, 74 (19)
  • [46] THE ROLE OF CELL-FREE CIRCULATING TUMOR DNA (CTDNA) DEFINED BY KRAS AND TP53 MUTATIONS IN THE ASSESSMENT OF COLORECTAL CANCER RECURRENCE: A META-ANALYSIS.
    Siddiqui, M.
    Bhoday, J.
    Chand, M.
    Freudian, M.
    Tekkis, P.
    Lim, E.
    Abulafi, A.
    Brown, G.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E219 - E220
  • [47] Simultaneous multiparametric profiling of cell-free RNA (cfRNA) and cell-free tumor DNA (ctDNA) in advanced-stage colorectal cancer
    Feng, Zheng
    Wang, Danyi
    Merkle, Dennis
    Yu, Jianjun
    Jia, Shidong
    Scheuenpflug, Juergen
    CLINICAL CANCER RESEARCH, 2020, 26 (11) : 45 - 45
  • [48] Cell-free circulating tumor DNA in colorectal cancer: a proof of concept with simplified methodology
    Bosque, Javier
    Guirao, Carlos
    Ferrandez, Asia
    Suarez, Noelia
    Isabel Castillejo, Maria
    Anguita, Diana
    Pamies, Maria
    Moya, Alejandro
    Luis Soto, Jose
    Gallego Plazas, Javier
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (10): : 1924 - 1931
  • [49] Cell-free mitochondrial DNA as a novel non-invasive biomarker for oral cancer
    Balachander, Kannan
    Paramasivam, Arumugam
    ORAL ONCOLOGY, 2022, 127
  • [50] Cell-free circulating tumor DNA in colorectal cancer: a proof of concept with simplified methodology
    Javier Bosque
    Carlos Guirao
    Asia Ferrández
    Noelia Suarez
    Maria Isabel Castillejo
    Diana Anguita
    María Pamies
    Alejandro Moya
    José Luis Soto
    Javier Gallego Plazas
    Clinical and Translational Oncology, 2022, 24 : 1924 - 1931